C12N 2830/75
From invertebrates
Official title: from invertebrates
C12N2830/75 (From invertebrates) appears on 47 US grants and 36 published applications in this corpus.
Search patents in C12N- Granted patents
- 47
- Published applications
- 36
- Assignees
- 34
- Inventors
- 118
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 0 | 0 |
| 2000 | 3 | 0 |
| 2001 | 6 | 0 |
| 2002 | 4 | 4 |
| 2003 | 3 | 6 |
| 2004 | 3 | 3 |
| 2005 | 1 | 1 |
| 2006 | 4 | 3 |
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 2 | 2 |
| 2010 | 0 | 2 |
| 2011 | 2 | 2 |
| 2012 | 2 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 2 |
| 2015 | 0 | 0 |
| 2016 | 1 | 3 |
| 2017 | 0 | 0 |
| 2018 | 1 | 2 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for insect control4 Aug 2026US 12,698,310 B2Indiana University Research and Technology Corporation
- Self-limiting noctuids9 Dec 2025US 12,492,404 B2Oxitec Limited
- Gene expression system using alternative splicing in insects9 Mar 2021US 10,941,416 B2Oxitec Limited
- Gene expression system using alternative splicing in insects15 May 2018US 9,970,025 B2Oxitec Limited
- Vectors conditionally expressing protein2 Aug 2016US 9,402,919 B2Intrexon Corporation
- Compositions and methods for insect control26 Jan 2023US 2023/0022700 A1Indiana University Research and Technology Corporation
- Self-Limiting Noctuids31 Mar 2022US 2022/0098597 A1Oxitec Limited
- Compositions and methods for insect control2 May 2019US 2019/0127425 A1Indiana University Research and Technology Corporation
- Vectors Conditionally Expressing Protein6 Dec 2018US 2018/0344876 A1Intrexon Corporation
- Gene expression system using alternative splicing in insects6 Sep 2018US 2018/0251785 A1Oxitec Limited
Most cited
By later US patents
- Eukaryotic transposable element99US 6,159,717 AInstitute for Molecular Biology & Biotechnology/FORTH · 2000
- Methods of modulating the expression of genes using ultraspiracle receptor68US 6,265,173 B1The Salk Institute for Biological Studies · 2001
- Method for modulating expression of exogenous genes in mammalian systems, and products related thereto56US 6,723,531 B2The Salk Institute for Biological Studies · 2004
- DNA encoding retinoid receptor X (RXR) alpha and gamma; corresponding vectors and host cells55US 5,723,329 AThe Salk Institute for Biological Studies · 1998
- Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor51US 6,281,330 B1The Salk Institute of Biological Studies · 2001